Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Jonathan Temte MD, PhD
Jonathan Temte MD, PhD Advisory Board
Nekesha Oliphant MD
Nekesha Oliphant MD Advisory Board
Irene Hamrick MD, FAAFP, AGSF, CMD
Irene Hamrick MD, FAAFP, AGSF, CMD Advisory Board
See All Experts
story of the week
Published in Primary Care and
2 other channels

Journal Scan / Research · October 02, 2019

Ticagrelor ± Aspirin in High-Risk Patients After PCI

The New England Journal of Medicine

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Deepak Bhatt MD, MPH, FACC, FAHA, FESC, MSCAI

Peter Lin MD, CCFP

The New England Journal of Medicine
Ticagrelor With or Without Aspirin in High-Risk Patients After PCI
N. Engl. J. Med 2019 Sep 26;[EPub Ahead of Print], R Mehran, U Baber, SK Sharma, DJ Cohen, DJ Angiolillo, C Briguori, JY Cha, T Collier, G Dangas, D Dudek, V Džavík, J Escaned, R Gil, P Gurbel, CW Hamm, T Henry, K Huber, A Kastrati, U Kaul, R Kornowski, M Krucoff, V Kunadian, SO Marx, SR Mehta, D Moliterno, EM Ohman, K Oldroyd, G Sardella, S Sartori, R Shlofmitz, PG Steg, G Weisz, B Witzenbichler, Y Han, S Pocock, CM Gibson

Further Reading

Most Read This Week

Recently Updated